Cargando…
Dosimetric characterization of GMS BT‐125‐1 (125)I radioactive seed with Monte Carlo simulations and experimental measurement
PURPOSE: To investigate the dosimetric characteristics of the new GMS BT‐125‐1 (125)I radioactive seed, including dose rate constant, radial dose functions, and anisotropy functions. METHODS: Dosimetric parameters of GMS BT‐125‐1 (125)I seed including dose rate constant, radial dose functions, and a...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5689916/ https://www.ncbi.nlm.nih.gov/pubmed/28905514 http://dx.doi.org/10.1002/acm2.12173 |
_version_ | 1783279485710237696 |
---|---|
author | Zhao, Nan Yang, Ruijie Ren, Li Fan, Yi Li, Junli Zhang, Jianguo |
author_facet | Zhao, Nan Yang, Ruijie Ren, Li Fan, Yi Li, Junli Zhang, Jianguo |
author_sort | Zhao, Nan |
collection | PubMed |
description | PURPOSE: To investigate the dosimetric characteristics of the new GMS BT‐125‐1 (125)I radioactive seed, including dose rate constant, radial dose functions, and anisotropy functions. METHODS: Dosimetric parameters of GMS BT‐125‐1 (125)I seed including dose rate constant, radial dose functions, and anisotropy functions were calculated using the Monte Carlo code of MCNP5, and measured with thermoluminescent dosimeters (TLDs). The results were compared with those of PharmaSeed BT‐125‐1, PharmaSeed BT‐125‐2 (125)I, and model 6711 (125)I seeds. RESULTS: The dose rate constant of GMS BT‐125‐1 (125)I seed was 0.959 [Formula: see text] , with the difference of 0.94%, 0.83%, and 0.73% compared with the PharmaSeed BT‐125‐1 (125)I seed, PharmaSeed BT‐125‐2 (125)I seed, and Model 6711 (125)I seed, respectively. For radial dose function, the differences between the Monte Carlo and the experimental g(r) results were mostly within 10%. Monte Carlo results of g(r) for GMS BT‐125‐1 (125)I seed were found in agreement (within 3.3%) with corresponding results for the PharmaSeed BT‐125‐2 (125)I seed. The largest differences were 8.1% and 6.2% compared with PharmaSeed BT‐125‐1 (125)I seed and model 6711 (125)I seed, respectively. For anisotropy function, the difference between GMS BT‐125‐1 (125)I seed and PharmaSeed BT‐125‐2 (125)I seed was typically <10%. CONCLUSIONS: The measured dose rate constant, radial dose functions, and two‐dimensional anisotropy functions for the GMS BT‐125‐1 (125)I seed showed good agreement with the Monte Carlo results. The dose rate constant of the GMS BT‐125‐1 (125)I seed is similar to that of the PharmaSeed BT‐125‐1 (125)I seed, the PharmaSeed BT‐125‐2 (125)I seed, and the model 6711 (125)I seed. For radial dose functions and two‐dimensional anisotropy functions, the GMS BT‐125‐1 (125)I seed is similar to the PharmaSeed BT‐125‐2 (125)I seed but different from the PharmaSeed BT‐125‐1 (125)I seed and the model 6711 (125)I seed. |
format | Online Article Text |
id | pubmed-5689916 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-56899162018-04-02 Dosimetric characterization of GMS BT‐125‐1 (125)I radioactive seed with Monte Carlo simulations and experimental measurement Zhao, Nan Yang, Ruijie Ren, Li Fan, Yi Li, Junli Zhang, Jianguo J Appl Clin Med Phys Radiation Oncology Physics PURPOSE: To investigate the dosimetric characteristics of the new GMS BT‐125‐1 (125)I radioactive seed, including dose rate constant, radial dose functions, and anisotropy functions. METHODS: Dosimetric parameters of GMS BT‐125‐1 (125)I seed including dose rate constant, radial dose functions, and anisotropy functions were calculated using the Monte Carlo code of MCNP5, and measured with thermoluminescent dosimeters (TLDs). The results were compared with those of PharmaSeed BT‐125‐1, PharmaSeed BT‐125‐2 (125)I, and model 6711 (125)I seeds. RESULTS: The dose rate constant of GMS BT‐125‐1 (125)I seed was 0.959 [Formula: see text] , with the difference of 0.94%, 0.83%, and 0.73% compared with the PharmaSeed BT‐125‐1 (125)I seed, PharmaSeed BT‐125‐2 (125)I seed, and Model 6711 (125)I seed, respectively. For radial dose function, the differences between the Monte Carlo and the experimental g(r) results were mostly within 10%. Monte Carlo results of g(r) for GMS BT‐125‐1 (125)I seed were found in agreement (within 3.3%) with corresponding results for the PharmaSeed BT‐125‐2 (125)I seed. The largest differences were 8.1% and 6.2% compared with PharmaSeed BT‐125‐1 (125)I seed and model 6711 (125)I seed, respectively. For anisotropy function, the difference between GMS BT‐125‐1 (125)I seed and PharmaSeed BT‐125‐2 (125)I seed was typically <10%. CONCLUSIONS: The measured dose rate constant, radial dose functions, and two‐dimensional anisotropy functions for the GMS BT‐125‐1 (125)I seed showed good agreement with the Monte Carlo results. The dose rate constant of the GMS BT‐125‐1 (125)I seed is similar to that of the PharmaSeed BT‐125‐1 (125)I seed, the PharmaSeed BT‐125‐2 (125)I seed, and the model 6711 (125)I seed. For radial dose functions and two‐dimensional anisotropy functions, the GMS BT‐125‐1 (125)I seed is similar to the PharmaSeed BT‐125‐2 (125)I seed but different from the PharmaSeed BT‐125‐1 (125)I seed and the model 6711 (125)I seed. John Wiley and Sons Inc. 2017-09-14 /pmc/articles/PMC5689916/ /pubmed/28905514 http://dx.doi.org/10.1002/acm2.12173 Text en © 2017 The Authors. Journal of Applied Clinical Medical Physics published by Wiley Periodicals, Inc. on behalf of American Association of Physicists in Medicine. This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Radiation Oncology Physics Zhao, Nan Yang, Ruijie Ren, Li Fan, Yi Li, Junli Zhang, Jianguo Dosimetric characterization of GMS BT‐125‐1 (125)I radioactive seed with Monte Carlo simulations and experimental measurement |
title | Dosimetric characterization of GMS BT‐125‐1 (125)I radioactive seed with Monte Carlo simulations and experimental measurement |
title_full | Dosimetric characterization of GMS BT‐125‐1 (125)I radioactive seed with Monte Carlo simulations and experimental measurement |
title_fullStr | Dosimetric characterization of GMS BT‐125‐1 (125)I radioactive seed with Monte Carlo simulations and experimental measurement |
title_full_unstemmed | Dosimetric characterization of GMS BT‐125‐1 (125)I radioactive seed with Monte Carlo simulations and experimental measurement |
title_short | Dosimetric characterization of GMS BT‐125‐1 (125)I radioactive seed with Monte Carlo simulations and experimental measurement |
title_sort | dosimetric characterization of gms bt‐125‐1 (125)i radioactive seed with monte carlo simulations and experimental measurement |
topic | Radiation Oncology Physics |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5689916/ https://www.ncbi.nlm.nih.gov/pubmed/28905514 http://dx.doi.org/10.1002/acm2.12173 |
work_keys_str_mv | AT zhaonan dosimetriccharacterizationofgmsbt1251125iradioactiveseedwithmontecarlosimulationsandexperimentalmeasurement AT yangruijie dosimetriccharacterizationofgmsbt1251125iradioactiveseedwithmontecarlosimulationsandexperimentalmeasurement AT renli dosimetriccharacterizationofgmsbt1251125iradioactiveseedwithmontecarlosimulationsandexperimentalmeasurement AT fanyi dosimetriccharacterizationofgmsbt1251125iradioactiveseedwithmontecarlosimulationsandexperimentalmeasurement AT lijunli dosimetriccharacterizationofgmsbt1251125iradioactiveseedwithmontecarlosimulationsandexperimentalmeasurement AT zhangjianguo dosimetriccharacterizationofgmsbt1251125iradioactiveseedwithmontecarlosimulationsandexperimentalmeasurement |